Abiopharma

Clinical trial NCT07219238: start date: 2026-05-01 → 2026-10-01.

Clinical trial NCT03213041 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2023-07-01 → 2022-03-30 3. primary completion date: 2022-06-01 → 2021-06-01 4. enrollment: 100 → 12 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05029999 updates: 1. completion date: 2026-04-20 → 2029-04-20 2. primary completion date: 2026-04-20 → 2028-04-20 3. collaborators added: National Cancer Institute (NCI) 4. collaborators removed: National Institutes of Health (NIH)

Clinical trial NCT07074496 updates: 1. status: ACTIVE_NOT_RECRUITING → RECRUITING 2. primary completion date: 2026-07-01 → 2025-11-15

Clinical trial NCT03833479 updates: 1. completion date: 2025-12-01 → 2028-07-31 2. primary completion date: 2025-12-01 → 2028-07-31

Clinical trial NCT07641881 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-05-29

Clinical trial NCT07431086 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-12-28 → 2026-12-18 3. primary completion date: 2026-11-23 → 2026-11-13 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT01742299: enrollment: 155 → 250 participants.

Clinical trial NCT07539090: start date: 2026-06-01 → 2026-06-05.

Clinical trial NCT07346495: completion date: 2027-01-01 → 2026-08-01.